Salute e Benessere
A milestone moment for Interlinked - first major distribution agreement signed with a guaranteed minimum revenue of € 3 million
" " says , CEO and co-founder of Interlinked AB.
ReLink® is a patented, double-valved safety connector designed to reduce accidental catheter dislodgement, increase patient safety and reduce healthcare costs. The product is currently used within IV therapy, drainage, and veterinary care.
This agreement is the first of several planned launches as Interlinked enters a phase of international expansion.
Interlinked is a Swedish MedTech company with a CE-MDR-approved medical technology platform that enhances patient safety, improves clinical workflows, and reduces healthcare costs. The company is now entering a phase of accelerated growth and international market expansion.
Interlinked welcomes dialogue with investors, partners, and stakeholders who wish to be part of the company's next steps as we scale internationally.
Katarina Hedbeck, CEO
katarina.hedbeck@interlinked.care
www.interlinked.care
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/interlinked/r/a-milestone-moment-for-interlinked---first-major-distribution-agreement-signed-with-a-guaranteed-min,c4264232
The following files are available for download:
View original content:https://www.prnewswire.co.uk/news-releases/a-milestone-moment-for-interlinked--first-major-distribution-agreement-signed-with-a-guaranteed-minimum-revenue-of--3-million-302609981.html